http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2540501-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_592638d9e8f3946ee52e303f6335f38a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-14
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-14
filingDate 1983-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a56b3bfdd7d20c60bdbf2ac10fc804e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b57340d1ffea6b44f93d3a33113b8e42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a75fe759f66fa4ffe0558cc7cc9920e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a26c298b06cecb335756a2dd4918ecfb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f98ec9ce0df30b978c2f0239e23b9e43
publicationDate 1984-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2540501-A1
titleOfInvention NEW CYCLICAL ANALOGUE OF ANGIOTENSIN FROM CYCLO (1E-8) - / LYSI / ANGIOTENSIN
abstract THE INVENTION CONCERNS MEDICINE. THE CYCLICAL ANALOGUE OF ANGIOTENSIN, WHICH IS THE OBJECT OF THE INVENTION, IS CHARACTERIZED IN THAT IT IS CONSTITUTED BY THE CYCLO (I-8) -LYS-ANGIOTENSIN RESPONDING TO THE FORMULA: (CF DRAWING IN BOPI) THE PRODUCT IN QUESTION EXERCISES A HYPOTENSIVE EFFECT AND CAN BE USED IN MEDICINE AS AN ACTIVE PRINCIPLE OF A MEDICINAL PRODUCT.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0171270-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0171270-A3
priorityDate 1983-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15607819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450857920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449702073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453592467
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6992304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453552148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419495462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406968478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448008838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426383573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10928
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396415
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153798904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416157402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID631653
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2734718
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67852048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10351092
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22728543
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10906
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429278076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414867419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413982712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411320478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416045689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69568

Total number of triples: 50.